GL1X · GenesisL1 explorer

Research workbench

Histamine methyltransferase complexed with the antimalarial drug amodiaquine

Analyse Histamine methyltransferase complexed with the antimalarial drug amodiaquine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2AOU
Type
protein
Length
577 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histamine N-methyltransferase
EC
2.1.1.8
UniProt
P50135
Ligands
CQA
Pockets
3 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistamine N-methyltransferase (EC 2.1.1.8)protein28843% helix, 23% strandP50135
BHistamine N-methyltransferaseprotein28944% helix, 23% strandP50135

Ligands and binding sites

  • CQA · 4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol · ligand · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15650.780.8465CQA
26710.780.8366CQA
35710.680.7862empty

Interfaces

1 interface between chains.

  • A–B · 415 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified, 1 d-amino (oxidation, D-amino acid).

Compared structures

  • 2AOU · Histamine Methyltransferase Complexed with the Antimalarial Drug Amodiaquine · the same entry in another collection · chain A against A, TM-score 1.00
  • P50135 · AlphaFold monomer V2.0 prediction for histamine N-methyltransferase (P50135) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.